Life as a federal registrant

Federal minimums for Schedule III substances cover four categories: receipts, dispositions, inventory, and any losses or thefts.

The good news for OMMA-licensed operators: the state already requires most of this. Your seed-to-sale tracking system — Metrc, BioTrack, or equivalent — captures the transaction-level detail that satisfies federal recordkeeping for receipts and dispositions. The federal rule accepts state-required records to the maximum extent the treaty and federal statute allow.

For most operators with mature state-side tracking, the incremental federal recordkeeping burden is minimal. The records you're already keeping generally work.

Every two years, a comprehensive physical count of all controlled substances on hand at the registered location. Not an estimate — an actual count.

The inventory needs to document each substance, its form, quantity, and location. Records must be kept for at least two years and be ready for DEA inspection.

For most dispensaries and processors running Metrc, your system-of-record inventory should track closely to the physical count. The biennial inventory is largely a verification exercise against what your state tracking system already shows.

State-law security requirements substitute for federal ones where the state regime is robust enough. OMMA's security requirements — vault storage, alarmed perimeters, camera coverage, restricted access, transport security — meet or exceed federal Schedule III minimums in most respects.

For standard dispensary, processing, and cultivation operations, your existing OMMA-compliant security setup generally satisfies the federal standard. You're not building a second security layer on top of what you already have.

The exception is activity where state law is silent — primarily import/export operations and certain specific manufacturing protocols. Those areas run against federal minimums directly. For the typical OMMA medical operator, import/export won't apply.

The federal warning required by 21 U.S.C. § 825(c) for controlled substances. The exact language is set by statute and DEA implementing regulations — it's not something you write yourself.

This is the one packaging requirement that gets added on top of your existing OMMA-compliant labels. Everything else on your label stays as-is under state law. The federal warning goes on in addition.

Get the exact language from the DEA Diversion Control Division site or through your counsel before you update your packaging. The wording is specific.

State law covers almost everything. OMMA labeling and packaging requirements remain in full effect: cannabinoid content, dosage information, testing results, dispensary and patient identification, child-resistant packaging where required.

The federal registration adds one thing: the Section 825(c) warning label described above.

The implementing regulations explicitly exempt registered operators from the federal Part 1302 labeling and packaging requirements when they're complying with state law and adding the federal warning. You're regulated once, under OMMA rules, with the federal warning label added on.

State-law disposal protocols are accepted. OMMA requires documented destruction of unused, expired, or unsalable cannabis — most operators have an established disposal procedure already.

Metrc captures disposal events. Those records satisfy the federal documentation requirement.

If OMMA's disposal requirements and procedures are already in your SOPs and tracked in Metrc, your federal disposal obligations are covered by what you're already doing.

DEA inspectors can enter your registered premises during normal business hours for compliance inspections. For most routine inspections, you'll get advance notice. Unannounced inspections are reserved for specific cause — a complaint, a diversion flag, or something that comes up in a review.

For manufacturers specifically, there's an additional element during the period of the nominal-price purchase-and-resale mechanism (see the manufacturers question below). DEA has access to storage facilities during that process.

For dispensaries: routine federal inspections will be relatively infrequent in the early years. DEA has finite capacity and a large new registration population to manage. Expect state inspections to remain more frequent than federal ones for the foreseeable future.

This one affects growers and manufacturers only — not distributors or dispensaries.

Here's the background. A 1961 international treaty the U.S. signed — the Single Convention on Narcotic Drugs — requires the federal government to maintain a monopoly on wholesale trade in narcotic crops. For cannabis, that would normally mean the government actually takes possession of the crop at some point in the supply chain.

Rather than physically seizing state-licensed cannabis, the DEA executes a paper transaction: it "purchases" the manufacturer's crop at a nominal price, then immediately "sells" it back to the manufacturer at that same price plus a small administrative fee. The crop never physically moves. The federal monopoly requirement is satisfied on paper. The April 23 order also frames state-licensed marijuana as expressly exempt from parts of the treaty's monopoly requirement, so the paper transaction is one piece of the treaty-compliance posture, not the whole picture.

It's a regulatory technicality. Understand it's coming and what it means.

Permits are required for any cross-border movement of state-licensed medical cannabis. Required even if everything else about the activity is legal under state and federal Schedule III rules.

For the vast majority of OMMA-licensed operators, this will never come up. The permits matter most for FDA-approved drug-product manufacturers — Epidiolex-type products moving in pharmaceutical supply chains — and for whatever future interstate commerce framework might eventually emerge.

If import or export isn't part of your current operation, this requirement is theoretical for now.

Federal reporting requirements are satisfied by state seed-to-sale tracking where the state system captures the required data points. For OMMA operators on Metrc, that's most of it.

What DEA needs to see: acquisitions, dispositions, inventory levels, and any losses or thefts. Metrc captures all of those as part of OMMA compliance. The federal layer is satisfied by the state layer for the most part.

Operators in states with weaker tracking face more incremental federal burden. Oklahoma's Metrc requirement is one of the reasons OMMA-licensed operators generally have an easier post-registration compliance transition than operators in states that don't mandate seed-to-sale tracking.

Pre-registration: an initial inspection of the registered location is common, particularly for manufacturers and distributors. DEA will want eyes on the physical facility before granting the registration in many cases.

Post-registration: routine compliance inspections vary by activity type. Manufacturers see more frequent attention than dispensaries. For most OMMA-licensed dispensaries, expect federal inspection frequency to be relatively low in the early years — DEA is managing a large new registration population and has limited capacity.

Complaint-driven and cause-based inspections are unannounced and operate on a different track. If a specific concern is flagged — a diversion incident, a compliance complaint — that inspection doesn't wait for the routine schedule.

DEA registrations are tied to the specific entity that holds them. They don't transfer automatically.

In an asset acquisition — where the buyer is purchasing the business assets rather than the entity itself — the buyer needs to file its own registration. There's a gap between closing and the new registration being granted; plan for it.

In a stock acquisition, where the legal entity itself is purchased and continues operating unchanged, a modification to the existing registration may cover the ownership change rather than requiring a fresh application. That's a more favorable outcome but still requires DEA notification and processing.

M&A planning needs to include DEA registration treatment as a closing condition. An operator without a plan for the federal registration gap is creating a period where its operations lack federal-law cover.

The federal registration suspends automatically. Immediately — there's no grace period where the federal registration stays active after the state license goes away.

Reinstatement of the federal registration follows reinstatement of the OMMA license, but it's not automatic. A notification process with DEA is required. The federal registration doesn't simply reactivate when the state license is restored; you have to notify DEA and complete the reinstatement process.

The practical priority: maintaining OMMA compliance is the single highest-priority federal compliance obligation, because losing the state license means losing the federal registration at the same moment.